— Know what they know.
Not Investment Advice

TLPH NASDAQ

Talphera, Inc.
1W: -4.2% 1M: -5.8% 3M: -4.2% YTD: -2.6% 1Y: +21.1% 3Y: +101.8% 5Y: -94.7%
$1.13
+0.01 (+0.89%)
 
Weekly Expected Move ±3.5%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · $58.6M mcap · 27M float · 0.982% daily turnover · Short 57% of daily vol

Income Trends

Revenue
$28K +0.0% ▲
5Y CAGR: -65.1%
Gross Profit
$0 +100.0% ▲
Operating Income
-$13M +11.6% ▲
Net Income
-$14M -9.9% ▼
EPS (Diluted)
$-0.34 +32.0% ▲
EBITDA
-$13M +11.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$378K$0$651K$0$28K
YoY Growth-48.0%-37.2%-63.2%-100.0%+0.0%
Cost of Revenue$3M$2M$6M$7M$0
Gross Profit-$3M-$2M-$5M-$7M$0
Gross Margin-695.2%—-751.9%—0.0%
R&D Expenses$2M$2M$6M$7M$6M
SG&A Expenses$0$17M$0$0$7M
Operating Expenses$15M$19M$12M$9M$14M
Operating Income-$18M-$20M-$17M-$15M-$13M
Operating Margin-4792.6%—-2594.3%—-48157.1%
Interest Expense$2M$1M$134K$394K$0
Income Before Tax-$17M$59M-$10M-$13M-$14M
Tax Expense$5K$13K$0$0$0
Net Income-$35M$43M-$18M-$13M-$14M
Net Margin-9285.4%—-2826.0%—-51035.7%
EPS (Diluted)$-5.86$5.72$-1.29$-0.50$-0.34
EBITDA-$16M$62M-$17M-$15M-$13M
Shares Outstanding6M7M14M26M42M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms